The loss of PTEN function has been mechanistically linked to metastasis5, and lack of radio-therapy6 and chemo-therapy7, 8 response in brain and breast cancer patients, indicating that PTEN is a key regulator of tumour sensitivity to multiple therapeutic approaches. The gene discussed is PTEN; the disease is breast cancer.